Status:
COMPLETED
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Brief Summary
This open label, non-interventional study is to show the efficacy of Crestor (rosuvastatin) in reduction of LDL-cholesterol and cardiovascular risk parameters in patients with hypercholesterolemia. Ef...
Eligibility Criteria
Inclusion
- a patient with hypercholesterolemia who has been prescribed Crestoraccording to physician's judgement, irrespective of the inclusion in the study.
- no treatment with any statin in the last 3 months
Exclusion
- hypersensitivity to rosuvastatin or any other ingredient of Crestor
- active liver disease, severe renal insufficiency
- myopathy or predisposing risk factors for myopathy/ rhabdomyolysis
- woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
602 Patients enrolled
Trial Details
Trial ID
NCT00837083
Start Date
January 1 2007
End Date
October 1 2007
Last Update
February 6 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.